Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells-Reference-Cited by-同舟云学术

Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells

Published:2013-11-15 Issue:22 Volume:12 Page:3471-3477
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Vazquez-Martin Alejandro,CUFÍ SÍLVIA,López-Bonet Eugeni,COROMINAS-FAJA BRUNA,CUYÀS ELISABET,Vellon Luciano,MANUEL IGLESIAS JUAN,LEIS OLATZ,Martin Angel,MENENDEZ MENENDEZ JAVIERABEL

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.26692

Reference23 articles.

1. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging;Menendez;Cell Cycle,2011

2. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells;Vazquez-Martin;Cell Cycle,2012

3. The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells;Menendez;Cell Cycle,2013

4. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway;Corominas-Faja;Cell Cycle,2013

5. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer;Chen;J Biol Chem,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipocyte-conditioned medium induces tamoxifen resistance by activating PI3K/Akt/mTOR pathway in estrogen receptor-positive breast cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

2. The multifaceted role of SOX2 in breast and lung cancer dynamics;Pathology - Research and Practice;2024-08

3. Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-02-28

4. Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death;Journal of Biochemical and Molecular Toxicology;2023-07-09

5. Gel-Free Single-Cell Culture Arrays on a Microfluidic Chip for Highly Efficient Expansion and Recovery of Colon Cancer Stem Cells;ACS Biomaterials Science & Engineering;2022-07-05